Has Carlton Cain received payments from drug or device companies?

Yes. Drug and device makers reported $4,502 in general payments to Carlton Cain across 157 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carlton Cain did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carlton Cain come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carlton Cain

Psychiatric/Mental Health · Troy, MINPI 1518435932

Payments from drug & device makers

$4,502in general payments, 2019–2025

Across 157 payments — averaging $28.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$779
AbbVie$777
Teva Pharmaceuticals USA, Inc.$621
Axsome Therapeutics, Inc.$435
Alkermes, Inc.$361
Corium, LLC$272
plus $1K from 14 others

What the payments were for

Food & beverage$4,502100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	19	$779
AbbVie	41	$777
Teva Pharmaceuticals USA, Inc.	18	$621
Axsome Therapeutics, Inc.	6	$435
Alkermes, Inc.	15	$361
Corium, LLC	12	$272
Supernus Pharmaceuticals, Inc.	2	$180
Lundbeck LLC	8	$152
Jazz Pharmaceuticals Inc.	1	$150
Johnson & Johnson	3	$136
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$135
E.r. Squibb & Sons, L.L.C.	2	$90
Takeda Pharmaceuticals U.S.A., Inc.	5	$87
Tris Pharma Inc	4	$71
Neurocrine Biosciences, Inc.	3	$61
Indivior Inc.	3	$55
Bioxcel Therapeutics, Inc.	3	$53
Vanda Pharmaceuticals Inc.	2	$44
OWP Pharmaceuticals, Inc.	2	$26
Ironshore Pharmaceuticals Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,502 in reported general payments places this provider in the 85th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RexultiBrexpiprazole	31	$56,444
TrintellixVortioxetine Hydrobromide	14	$6,980
Aripiprazole	37	$1,625
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	40	$799
Duloxetine Hcl	56	$741
Fluoxetine Hcl	37	$566
Quetiapine Fumarate	62	$522
Bupropion XlBupropion Hcl	26	$518
Trazodone Hcl	26	$378
Buspirone Hcl	26	$360
Mirtazapine	20	$353
Sertraline Hcl	35	$336
Prazosin Hcl	17	$253
Escitalopram Oxalate	20	$239
Oxcarbazepine	11	$209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti	$779	$56,44431 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$87	$6,98014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Troy

Jacquelyn TerryTroy$8K
Duren GutierrezSouthfield$207K
Tamlynn EvansTraverse City$78K
Shiba NixonClarkston$60K
Amy AmesClinton Township$43K
Cody ShinavierClarkston$41K
Oksana LidkeBattle Creek$30K
Jennifer Wims-MaddenPontiac$28K
Jessica ShantzWarren$21K
Gladys KimeliSaginaw$17K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →